Andrew Cooper
Cooper was appointed CEO of CluePoints in December 2022, bringing more than 24 years of clinical trial industry and software experience. He previously served as General Manager for the eCOA Business Unit at Clario (formerly ERT) and held leadership roles at Oracle and Medidata. CluePoints uses advanced statistics, machine learning, and AI to assess the quality, accuracy, and integrity of clinical trial data. The platform has over 9,500 users, has de-risked more than 1,600 studies, and detected over 142,000 issues for its customers.
Career
Roles
- European External Action ServiceInfrastructure SpecialistMay 2019 – Present
- Capgemini#23factorySenior Solutions ArchitectJul 2017 – Apr 2018
- Sogeti#150factorySolutions ArchitectJul 2008 – Jun 2017
- TransicielSenior ConsultantJun 2004 – Jun 2008
- IT SoftwareConsultantJan 1999 – May 2004
- Intergraph (New Zealand)Service ManagerApr 1994 – May 1998
Education
- University of Canterbury#231schoolME (Civil), Civil Engineering1985 - 1986
- University of Canterbury#231schoolBE (Civil), Civil Engineering1980 - 1984
- Kapiti College1975 - 1980
From public career histories · 9 entries